Investors in Pharma

SmiLe Incubator helps entrepreneurs and startup companies to develop and commercialize new ideas. Surrounded by smart and passionate people, as well as the best tools and approaches at your disposal – you’ll take leaps toward creating a business and connecting with the right people and resources. We offer business coaching, access to investor & industry networks, access to labs & instrument as well as a community with colleagues, friends and peers.

ODI Startup Accelerator is a year-long, bespoke programme for data-oriented startups. The ODI is a non-profit company, founded in 2012 by inventor of the web, Sir Tim Berners-Lee, and AI expert, Sir Nigel Shadbolt, and headquartered in King’s Cross, London, UK. Our mission is to work with companies and governments to build an open, trustworthy data ecosystem.

Development Capital, founded in 2013, provides €2-12 million in growth capital to Irish SMEs, focusing on export markets. With €100 million invested in 12 companies, they offer flexible investment structures and take minority stakes to support growth strategies like expansion, acquisitions, and management buyouts. They prioritize responsible investing by integrating ESG considerations into their process.

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by great entrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success.

Bayer Open Innovation's global innovation networks service offering enables clients to design, build and optimize innovation on a global scale through the creation of innovation networks that combine R&D, market intelligence, and local talent and resources.

Pierre Fabre Invest operates as an investment firm.Pierre Fabre Group, a French pharmaceutical and dermocosmetics company, is dedicated to developing innovative solutions for health and beauty. With a strong focus on pharmaceuticals and dermo-cosmetic products.

UCB Ventures is a €150 million strategic corporate venture fund. UCB is a global biopharmaceutical company focused on neurology and immunology disorders, driven by innovative science to enhance patient lives worldwide. We work closely and forge strong connections with patients, caregivers, health care professionals and other stakeholders who know the challenges of these diseases and where the unmet needs are found all too well.

Cube Labs, the venture builder in the healthcare technology space in Italy. We are venture builders enabling innovation in the healthcare technology space. We build companies from promising early-stage R&D, and provide entrepreneurial and operational support at all the stages of their life cycle to transform pioneering science into healthcare solutions.

European Equity Partners specializes in providing capital to high-growth companies in Northern Europe seeking external funding. As a dedicated investment firm, European Equity Partners focuses on identifying and supporting promising businesses with innovative ideas and scalable business models. Their investment strategy is centered around fostering growth and maximizing potential through strategic financial support and operational guidance. By leveraging their expertise and network, European Equity Partners aims to empower entrepreneurs and drive sustainable economic development in Northern Europe. They play a pivotal role in fueling innovation and entrepreneurship by offering tailored financial solutions and fostering long-term partnerships with ambitious companies poised for expansion.

Eurovestech PLC is an AIM-listed pan-European development capital fund that specializes in investing in high-technology enterprises. The firm focuses on identifying and supporting innovative companies across Europe with high growth potential, particularly in sectors such as technology and digital media. Eurovestech provides strategic development capital to help these enterprises accelerate their growth, expand their market presence, and achieve their strategic objectives. As a publicly listed company on the AIM market, Eurovestech offers investors the opportunity to participate in the growth of promising high-tech businesses through transparent and regulated investment vehicles. The firm's investment strategy emphasizes active management and value creation, aiming to maximize shareholder value while supporting the development of transformative technologies and businesses.

Rosetta Capital Limited operates as a private equity and venture capital firm specializing in direct secondary investments. The firm focuses on acquiring direct stakes in private companies from existing shareholders, providing liquidity and growth capital to support these businesses. Rosetta Capital's investment strategy involves identifying attractive opportunities in established companies with strong growth potential and sustainable business models. By leveraging its expertise in direct secondary transactions, the firm aims to generate value and foster growth within its portfolio companies. Rosetta Capital plays a crucial role in the secondary market, facilitating transactions that enable shareholders to realize value while positioning portfolio companies for continued success and expansion.

Founded in 2016, today Indaco Venture Partners SGR is the largest independent Italian venture capital asset management company, with a strong specialization in companies that innovate in electronics and robotics, medtech, digital and new materials. Indaco manages over 250 million across its five funds. Investments in Indaco Ventures Fund I are focused on growth-stage companies whose competitive advantage stems from cutting-edge proprietary technologies and innovations. In terms of teams and technologies, the focus is on Italian enterprises, although investments are made throughout Europe, USA, Canada and Israel. Anchor institutional investors in Indaco Ventures Fund I include Intesa Sanpaolo, Fondazione Cariplo and Fondo Italiano d'Investimento. In the digital sector, Indaco has an advisory partnership with growITup.